In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
|Podcasts|December 1, 2021
Diagnostic Testing During a Pandemic
A digital health company’s quest to improve the delivery and scaling of lab testing
Advertisement
Pouria Sanae, CEO of ixlayer, a technology company, explains the obstacles surrounding the distribution of remote lab tests pre-, during and post-pandemic, the shift to at-home Covid screenings, the logistical challenges in collaborating with different US regions, and the concept of the “pre-patient” model for preventative care.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related to this article
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: PhRMA Sues to Block GLOBE Model and Bayer's $2.2B Ohio Site
2
Why PhRMA Sued to Block Medicare's GLOBE Pricing Model
3
LogiPharma USA 2026: Data Readiness Must Come Before AI
4
Supply Chain Visibility Needs Context Before AI, Says PAXAFE’s Mark Talens
5